854 related articles for article (PubMed ID: 24667583)
1. The cost impact of short-term ventricular assist devices and extracorporeal life support systems therapies on the National Health Service in the UK.
Borisenko O; Wylie G; Payne J; Bjessmo S; Smith J; Firmin R; Yonan N
Interact Cardiovasc Thorac Surg; 2014 Jul; 19(1):41-8. PubMed ID: 24667583
[TBL] [Abstract][Full Text] [Related]
2. Extracorporeal Life Support Bridge to Ventricular Assist Device: The Double Bridge Strategy.
Marasco SF; Lo C; Murphy D; Summerhayes R; Quayle M; Zimmet A; Bailey M
Artif Organs; 2016 Jan; 40(1):100-6. PubMed ID: 25980985
[TBL] [Abstract][Full Text] [Related]
3. Minimally invasive CentriMag ventricular assist device support integrated with extracorporeal membrane oxygenation in cardiogenic shock patients: a comparison with conventional CentriMag biventricular support configuration.
Takeda K; Garan AR; Ando M; Han J; Topkara VK; Kurlansky P; Yuzefpolskaya M; Farr MA; Colombo PC; Naka Y; Takayama H
Eur J Cardiothorac Surg; 2017 Dec; 52(6):1055-1061. PubMed ID: 28651347
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Safety and Effectiveness of the Extracorporeal Continuous-Flow Ventricular Assist Device (BR16010) Use as a Bridge-to-Decision Therapy for Severe Heart Failure or Refractory Cardiogenic Shock: Study Protocol for Single-Arm Non-randomized, Uncontrolled, and Investigator-Initiated Clinical Trial.
Fukushima N; Tatsumi E; Seguchi O; Takewa Y; Hamasaki T; Onda K; Yamamoto H; Hayashi T; Fujita T; Kobayashi J
Cardiovasc Drugs Ther; 2018 Aug; 32(4):373-379. PubMed ID: 29948739
[TBL] [Abstract][Full Text] [Related]
5. Novel minimally invasive surgical approach using an external ventricular assist device and extracorporeal membrane oxygenation in refractory cardiogenic shock.
Takeda K; Garan AR; Topkara VK; Kirtane AJ; Karmpaliotis D; Kurlansky P; Yuzefpolskaya M; Colombo PC; Naka Y; Takayama H
Eur J Cardiothorac Surg; 2017 Mar; 51(3):591-596. PubMed ID: 27818380
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous cardiac assist devices compared with surgical hemodynamic support alternatives: cost-effectiveness in the emergent setting.
Maini B; Gregory D; Scotti DJ; Buyantseva L
Catheter Cardiovasc Interv; 2014 May; 83(6):E183-92. PubMed ID: 24130115
[TBL] [Abstract][Full Text] [Related]
7. Cardiac extracorporeal life support: state of the art in 2007.
Cooper DS; Jacobs JP; Moore L; Stock A; Gaynor JW; Chancy T; Parpard M; Griffin DA; Owens T; Checchia PA; Thiagarajan RR; Spray TL; Ravishankar C
Cardiol Young; 2007 Sep; 17 Suppl 2():104-15. PubMed ID: 18039404
[TBL] [Abstract][Full Text] [Related]
8. National trends in the utilization of short-term mechanical circulatory support: incidence, outcomes, and cost analysis.
Stretch R; Sauer CM; Yuh DD; Bonde P
J Am Coll Cardiol; 2014 Oct; 64(14):1407-15. PubMed ID: 25277608
[TBL] [Abstract][Full Text] [Related]
9. Extracorporeal membrane oxygenation support in refractory cardiogenic shock: treatment strategies and analysis of risk factors.
Loforte A; Marinelli G; Musumeci F; Folesani G; Pilato E; Martin Suarez S; Montalto A; Lilla Della Monica P; Grigioni F; Frascaroli G; Menichetti A; Di Bartolomeo R; Arpesella G
Artif Organs; 2014 Jul; 38(7):E129-41. PubMed ID: 24841637
[TBL] [Abstract][Full Text] [Related]
10. Extracorporeal life support in cardiogenic shock: Impact of acute versus chronic etiology on outcome.
Tarzia V; Bortolussi G; Bianco R; Buratto E; Bejko J; Carrozzini M; De Franceschi M; Gregori D; Fichera D; Zanella F; Bottio T; Gerosa G
J Thorac Cardiovasc Surg; 2015 Aug; 150(2):333-40. PubMed ID: 25869084
[TBL] [Abstract][Full Text] [Related]
11. The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation.
Clegg AJ; Scott DA; Loveman E; Colquitt J; Hutchinson J; Royle P; Bryant J
Health Technol Assess; 2005 Nov; 9(45):1-132, iii-iv. PubMed ID: 16303098
[TBL] [Abstract][Full Text] [Related]
12. Short-term mechanical circulatory support by veno-arterial extracorporeal membrane oxygenation in the management of cardiogenic shock and end-stage heart failure.
Brugts JJ; Caliskan K
Expert Rev Cardiovasc Ther; 2014 Feb; 12(2):145-53. PubMed ID: 24417434
[TBL] [Abstract][Full Text] [Related]
13. Cardiac replacement therapies: outcomes and costs for heart transplantation versus circulatory assist.
Mishra V; Fiane AE; Winsnes BA; Geiran O; Sørensen G; Hagen TP; Gude E
Scand Cardiovasc J; 2017 Feb; 51(1):1-7. PubMed ID: 27248460
[TBL] [Abstract][Full Text] [Related]
14. The Papworth experience with the Levitronix CentriMag ventricular assist device.
Shuhaiber JH; Jenkins D; Berman M; Parameshwar J; Dhital K; Tsui S; Large SR
J Heart Lung Transplant; 2008 Feb; 27(2):158-64. PubMed ID: 18267221
[TBL] [Abstract][Full Text] [Related]
15. Bridge-to-decision therapy with a continuous-flow external ventricular assist device in refractory cardiogenic shock of various causes.
Takayama H; Soni L; Kalesan B; Truby LK; Ota T; Cedola S; Khalpey Z; Uriel N; Colombo P; Mancini DM; Jorde UP; Naka Y
Circ Heart Fail; 2014 Sep; 7(5):799-806. PubMed ID: 25027874
[TBL] [Abstract][Full Text] [Related]
16. Costs associated with ventricular assist device use in children.
Mahle WT; Ianucci G; Vincent RN; Kanter KR
Ann Thorac Surg; 2008 Nov; 86(5):1592-7. PubMed ID: 19049755
[TBL] [Abstract][Full Text] [Related]
17. Short-Term Circulatory and Right Ventricle Support in Cardiogenic Shock: Extracorporeal Membrane Oxygenation, Tandem Heart, CentriMag, and Impella.
Sultan I; Kilic A; Kilic A
Heart Fail Clin; 2018 Oct; 14(4):579-583. PubMed ID: 30266366
[TBL] [Abstract][Full Text] [Related]
18. Evaluation and Comparison of Hemodynamic Performance of Three ECLS Systems in a Simulated Adult Cardiogenic Shock Model.
Ündar A; Wang S; Moroi M; Kunselman AR; Brehm CE
Artif Organs; 2018 Aug; 42(8):776-785. PubMed ID: 29575097
[TBL] [Abstract][Full Text] [Related]
19. Predictors of survival and ability to wean from short-term mechanical circulatory support device following acute myocardial infarction complicated by cardiogenic shock.
Garan AR; Eckhardt C; Takeda K; Topkara VK; Clerkin K; Fried J; Masoumi A; Demmer RT; Trinh P; Yuzefpolskaya M; Naka Y; Burkhoff D; Kirtane A; Colombo PC; Takayama H
Eur Heart J Acute Cardiovasc Care; 2018 Dec; 7(8):755-765. PubMed ID: 29094607
[TBL] [Abstract][Full Text] [Related]
20. Adequate systemic perfusion maintained by a CentriMag during acute heart failure.
Favaloro RR; Bertolotti A; Diez M; Favaloro L; Gomez C; Peradejordi M; Trentadue J; Hellman L; Arzani Y; Otero PV
Tex Heart Inst J; 2008; 35(3):334-9. PubMed ID: 18941648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
